Back

prof. dr. M.C. (Monique) Minnema

Full Professor

  • Department of Medical Oncology

Research Output (120)

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial

Wester Ruth, van der Holt Bronno, Asselbergs Emelie, Zweegman Sonja, Kersten Marie Jose, Vellenga Edo, Kooy Marinus van Marwijk, de Weerdt Okke, Minnema Monique, Lonergan Sarah, Palumbo Antonio, Lokhorst Henk, Broijl Annemiek, Sonneveld Pieter nov 2019, In: Haematologica. 104 , p. 2265-2273 9 p.

Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma

Braham Maaike V.J., Alblas Jacqueline, Dhert Wouter J.A., Öner F. Cumhur, Minnema Monique C. 30 okt 2019, In: Haematologica. 104 , p. E523-E526

Dexamethasone synergizes with MCL-1 inhibition in multiple myeloma through suppression of S6 phosphorylation

Spaan Ingrid, Timmerman Laura, Kimman Thoman, Slomp Anne, Cuenca Marta, Minnema Monique, Raymakers Reinier, Peperzak Victor okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E110-E110

Multiple myeloma with amplification of chromosome 1q is highly sensitive to MCL-1 targeting

Slomp Anne, Moesbergen Laura, Gong Jia-nan, Cuenca Marta, Borne Peter von dem, Sonneveld Pieter, Huang David, Minnema Monique, Peperzak Victor okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E49-E50

CD38 and CD45 expression on plasma cells and response to daratumumab in Multiple Myeloma

Lammers Eline, Cuenca Marta, Bloem Andries, Minnema Monique, Jak Margot okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E164-E164

A Highly Reproducible 3D Culture Approach for Functional Drug Testing on Primary Multiple Myeloma Cells.

Peperzak Victor, Cuenca Marta, Moesbergen Laura, van Nieuwenhuijzen Niels, Slomp Anne, Minnema Monique okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E97-E97

Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA

Sonneveld Pieter, Attal Michel, Perrot Aurore, Hulin Cyrille, Caillot Denis, Facon Thierry, Leleu Xavier, Belhadj-Merzoug Karim, Karlin Lionel, Benboubker Lofti, Levin Mark-David, Minnema Monique, Westerman Matthijs, Delforge Michel, Zweegman Sonja, Pei Lixia, de Boer Carla, Vanquickelberghe Veronique, Kampfenkel Tobias, Moreau Philippe okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E2-E3

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Lonial Sagar, Van de Donk Niels, Popat Rakesh, Zonder Jeffrey A., Minnema Monique, Larsen Jeremy T., Tuong Vi Nguyen , Chen Min S., Bensmaine Amine, Peluso Teresa, Sonneveld Pieter okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E52-E53

Eight versus four induction cycles of Carfilzomib, Thalidomide and Low-dose Dexamethasone: the Carthadex trial

Wester Ruth, Zweegman Sonja, Van der Holt Bronno, Jose Kersten Marie, Vellenga Edo, van Marwijk-Kooy Marinus, Asselbergs Emelie, de Weerdt Okke, Minnema Monique, Lonergan Sarah, Palumbo Antonio, Broijl Annemiek, Sonneveld Pieter okt 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E220-E221

Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options

Amaador K, Peeters H, Minnema M C, Nguyen T Q, Dendooven A, Vos J M I, Croockewit A J, van de Donk N W C J, Jacobs J F M, Wetzels J F M, Sprangers B, Abrahams A C sep 2019, In: Netherlands Journal of Medicine. 77 , p. 243-254 12 p.